Document Type : Case Report
Authors
- Eric Slawka 1
- Margarida Lourenço Castelló 1
- Gabriel Machado Romão da Silva 1
- Angelica dos Santos Vianna 2
1 Medical School, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
2 Clementino Fraga Filho University Hospital and Collective Health Studies Institute, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
Abstract
Introduction: Immune thrombocytopenia (ITP) is the most common cause of isolated thrombocytopenia in healthy individuals and can be classified as either primary or secondary. Drug use is an identifiable underlying cause for ITP. Toluene is a widely used solvent that is often contaminated with small amounts of benzene, a hematotoxic agent that can cause thrombocytopenia. Herein, we report a case of ITP in a patient with long-term low-level exposure to toluene in the workplace.
Case Report: A 34-year-old white female chemistry technician presented to a teaching hospital in Rio de Janeiro, Brazil, in 2002, with a 2-year history of isolated thrombocytopenia, and low-level occupational exposure to toluene for more than a decade. She had bruises on the physical exam, and platelets count of 40.000 µL. A diagnosis of primary ITP aggravated by benzene-contaminated toluene exposure was made. The treatment included definitive removal from exposure and changes in activities, with gradual improvement in the clinical condition and platelet count, although without normalization.
Discussion: We addressed the role of benzene as a toluene contaminant and an aggravating agent of primary ITP, a multifactorial disease that arises from different mechanisms. Although several substances may cause ITP, little attention has been paid to the role of toxicants such as benzene, a well-known hematotoxic agent.
Conclusion: This case highlights the role of benzene-contaminated toluene in ITP. As benzene is a hematotoxic agent, we recommend that proper health and environmental evaluations should consider benzene exposure in workplaces where toluene is used.
Keywords
Main Subjects
- Mititelu A, Onisâi MC, Roșca A, Vlădăreanu AM. Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options. Int J Mol Sci. 2024;25(4):2163.
- Martínez-Carballeira D, Bernardo Á, Caro A, Soto I, Gutiérrez L. Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective. Hematol Rep. 2024;16(2):204-19.
- Grimaldi-Bensouda L, Nordon C, Michel M, Viallard JF, Adoue D, Magy-Bertrand N, et al. Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome. Haematologica. 2016;101(9):1039-45.
- Jaime-Pérez JC, Ramos-Dávila EM, Meléndez-Flores JD, De Léon AG, Gómez-Almaguer D. Insights on chronic immune thrombocytopenia pathogenesis: A bench to bedside update. Blood Reviews. 2021;49:100827.
- Agency for Toxic Substances Disease Registry (ATSDR). Toxicological Profile for Toluene [Internet]. 2017. Available from: https://www.atsdr.cdc.gov/toxprofiles/tp56.pdf (Accessed May 27, 2024).
- Tharr D, Kudla I. Case Studies Exposure to Benzene-Contaminated Toluene and Bone Marrow Disorders—A Retrospective Exposure Assessment. Applied Occupational and Environmental Hygiene. 1997;12(1):11–14.
- Peckham T, Kopstein M, Klein J, Dahlgren J. Benzene-contaminated toluene and acute myeloid leukemia: a case series and review of literature. Toxicol Ind Health. 2014;30(1):73-81.
- American Society for Testing and Materials. (ASTM/D850-02e1). Standard Test Method for Distillation of Industrial Aromatic Hydrocarbons and Related Materials. [Internet]. 2002. Available from: https://standards.iteh.ai/catalog/standards/astm/c9ec42d6-93fa-48bc-b35e-61110aec011a/astm-d850-02e1>.6/26/2024. (Accessed Jun 18, 2024).
- Coker AK. Petroleum Refining Design and Applications Handbook, Volume 3. 1st Massachusetts: Scrivener Publishing LLC; 2018.
- Almeida G. Determination of causal associations in occupational medicine and the medico-legal context: references and standards. Rev Bras Med Trab. 2021;19(2):231-39.
- Bird MG, Wetmore BA, Letinski DJ, Nicolich M, Chen M, Schnatter AR, et al. Influence of toluene co-exposure on the metabolism and genotoxicity of benzene in mice using continuous and intermittent exposures. Chem Biol Interact. 2010;184(1-2):233-9.
- Lima AR. Toluene: correlation between occupational exposure limits and biological exposure indices. Rev Bras Med Trab. 2023 Feb 13;20(4):633-41.
- Lejeune J, Raoult V, Dubrasquet M, Chauvin R, Mallebranche C, Pellier I, et al. Prediction of the Clinical Course of Immune Thrombocytopenia in Children by Platelet Kinetics. HemaSphere. 2023;7(11):e960.
- Arnold DM, Cuker A. Uptodate. Drug-induced immune thrombocytopenia. [Internet]. 2024. Available from: https://sso.uptodate.com/contents/drug-induced-immune-thrombocytopenia?search=drug%20induced%20immune%20thrombocytopenia&source=search_result&selectedTitle=1%7E46&usage_type=default&display_rank=1 (Accessed Jun 18 2024).
- Vianna ASV, Rodriguez ICC, Matos LM, Santos ASE. Systemic Lupus Erythematosus and Occupational Exposure to Solvents: A Case Report. Asia Pac J Med Toxicol. 2022;11(4):172-76.
)